Atrial septal defect: A congenital heart condition with lifelong impact
Atrial septal defect: A congenital heart condition with lifelong impact
Atrial septal defect: A congenital heart condition with lifelong impact
An atrial septal defect (ASD) is a heart condition present from birth. It involves an opening in the wall that separates the heart's two upper chambers, known as the atria. The defect affects blood flow between these chambers and can lead to long-term health concerns if untreated.
ASD occurs when the septum—the wall dividing the left and right atria—fails to close properly during fetal development. Normally, this wall seals before birth, ensuring oxygen-rich and oxygen-poor blood remain separate. When an opening remains, extra blood flows into the right atrium and lungs, forcing the heart and lungs to work harder over time.
The condition is classified as a congenital heart defect, meaning it is present at birth. While some small defects may close on their own during early childhood, larger or persistent openings often require medical intervention. Treatment options can include monitoring, medication, or surgical repair, depending on the size and symptoms.
Despite its impact, precise global figures on the number of people living with a diagnosed ASD remain unclear. Available data does not provide specific prevalence or incidence rates for the condition, making it difficult to assess its full scale.
ASD is a lifelong condition that can vary in severity. Early detection and appropriate management help reduce complications and improve long-term outcomes. Without accurate global statistics, awareness and regular medical check-ups remain key for those affected.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?